From the Division of Plastic and Reconstructive Surgery.
College of Medicine, Medical University of South Carolina, Charleston, SC.
Ann Plast Surg. 2021 Jun 1;86(6S Suppl 5):S560-S566. doi: 10.1097/SAP.0000000000002882.
Postmastectomy implant-based breast reconstruction (IBR) in the setting of radiation (XRT) comes with a high risk of perioperative complications regardless of reconstruction method. The aim of study was to identify the effects of XRT on IBR using a prepectoral versus submuscular approach.
A retrospective chart review was performed after institutional review board approval was obtained. Patients at a single institution who had 2-stage IBR from June 2012 to August 2019 were included. Patients were separated into 4 groups: prepectoral with XRT (group 1), prepectoral without XRT (group 2), submuscular with XRT (group 3), and submuscular without XRT (group 4). Patient demographics, comorbidities, and postoperative complications were recorded and analyzed.
Three hundred eighty-seven breasts among 213 patients underwent 2-stage IBR. The average age and body mass index were 50.10 years and 29.10 kg/m2, respectively. One hundred nine breasts underwent prepectoral reconstruction (44 in group 1, 65 in group 2), and 278 breasts underwent submuscular reconstruction (141 in group 3, 137 in group 4). Prepectoral tissue expander placement was associated with higher complication rates in the radiated group (38.6% compared with 34.0% submuscular) and lower complication rates in the nonradiated group (26.2% compared with 29.2% submuscular), although significantly less explants were performed in prepectoral group, regardless of XRT status. The 3 most common complications overall were contracture (15.1% radiated, 10.4% nonradiated), infection (18.4% radiated, 11.9% nonradiated), and seroma (15.7% radiated, 10.9% nonradiated).
Two-stage, prepectoral tissue expander placement performs clinically better than submuscular in nonradiated patients compared with radiated patients; however, no statistical significance was identified. Prepectoral had a significantly less incidence of reconstructive failure than submuscular placement regardless of XRT status. Future larger-scale studies are needed to determine statistically significant difference in surgical approach.
在接受放射治疗(XRT)的情况下,乳房切除术后植入物乳房重建(IBR)的围手术期并发症风险很高,无论重建方法如何。本研究的目的是使用胸肌前与胸肌后入路来确定 XRT 对 IBR 的影响。
在获得机构审查委员会批准后,进行了回顾性图表审查。本研究纳入了 2012 年 6 月至 2019 年 8 月在一家医疗机构接受 2 期 IBR 的患者。将患者分为 4 组:接受 XRT 的胸肌前组(第 1 组)、未接受 XRT 的胸肌前组(第 2 组)、接受 XRT 的胸肌后组(第 3 组)和未接受 XRT 的胸肌后组(第 4 组)。记录并分析患者的人口统计学资料、合并症和术后并发症。
213 例患者中有 387 个乳房接受了 2 期 IBR。平均年龄和体重指数分别为 50.10 岁和 29.10kg/m2。109 个乳房接受了胸肌前重建(第 1 组 44 个,第 2 组 65 个),278 个乳房接受了胸肌后重建(第 3 组 141 个,第 4 组 137 个)。在接受放射治疗的患者中,胸肌前组织扩张器放置与更高的并发症发生率(38.6%比胸肌后 34.0%)相关,而在未接受放射治疗的患者中,胸肌前组织扩张器放置与更低的并发症发生率(26.2%比胸肌后 29.2%)相关,尽管在胸肌前组中进行了更多的切除手术,无论 XRT 状态如何。总体而言,最常见的 3 种并发症是挛缩(放射治疗组 15.1%,非放射治疗组 10.4%)、感染(放射治疗组 18.4%,非放射治疗组 11.9%)和血清肿(放射治疗组 15.7%,非放射治疗组 10.9%)。
与接受放射治疗的患者相比,2 期胸肌前组织扩张器放置在未接受放射治疗的患者中比胸肌后入路的临床效果更好;然而,未发现统计学意义。无论 XRT 状态如何,胸肌前入路的重建失败发生率明显低于胸肌后入路。需要进行更大规模的未来研究来确定手术入路的统计学差异。